Researchers at Brooke Army Medical Center in San Antonio, Texas tested the vaccine in 163 women with those tumors.
It was shown to cut the risk of death in half.
The study also showed a lower recurrence of cancer for some treated with the vaccine.
A larger study must now be conducted.